Self-assembled dehydropeptide nanocarrier as a delivery system for antitumor drug temozolomide
Authors:
- 27 April 2022
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 124, 105842
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- SHELXT– Integrated space-group and crystal-structure determinationActa Crystallographica Section A Foundations and Advances, 2015
- Crystal structure refinement withSHELXLActa Crystallographica Section C Structural Chemistry, 2015
- α,β-Dehydroamino acids in naturally occurring peptidesAmino Acids, 2014
- Self-assembled dipeptide nanotubes constituted by flexible β-phenylalanine and conformationally constrained α,β-dehydrophenylalanine residues as drug delivery systemJournal of Materials Chemistry B, 2014
- Development of a new UPLC‐MSMS method for the determination of temozolomide in mice: application to plasma pharmacokinetics and brain distribution studyBiomedical Chromatography, 2013
- Prodrug-based intracellular delivery of anticancer agentsAdvanced Drug Delivery Reviews, 2011
- The safety of temozolomide in the treatment of malignanciesExpert Opinion on Drug Safety, 2009
- OLEX2: a complete structure solution, refinement and analysis programJournal of Applied Crystallography, 2009
- A CD Exciton Chirality Method for Determination of the Absolute Configuration of threo-β-Aryl-β-hydroxy-α-amino Acid DerivativesThe Journal of Organic Chemistry, 2002
- Rheological characterisation of polymer gelsProgress in Polymer Science, 1998